|
|
Volumn 24, Issue 4, 2006, Pages 368-
|
|
Consequences
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD28 ANTIGEN;
MONOCLONAL ANTIBODY;
TGN 1412;
UNCLASSIFIED DRUG;
ANTIGEN SPECIFICITY;
BIOLOGICAL THERAPY;
BIOTECHNOLOGY;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
EDITORIAL;
HEALTH CARE;
HUMAN;
IMMUNE RESPONSE;
IMMUNE SYSTEM;
IMMUNOGENICITY;
INTENSIVE CARE;
LYMPHATIC LEUKEMIA;
MULTIPLE ORGAN FAILURE;
PRIORITY JOURNAL;
PUBLIC RELATIONS;
SKIN;
T LYMPHOCYTE ACTIVATION;
TREATMENT FAILURE;
UNCONSCIOUSNESS;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS;
DRUG APPROVAL;
DRUG EVALUATION, PRECLINICAL;
GERMANY;
RESEARCH;
|
|
EID: 33645745389
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0406-368a Document Type: Editorial |
|
Times cited : (4)
|
|
References (0)
|